Chronic

|

1

FDA Gives INVOKANA® Priority Review to Treat Chronic Kidney Disease in Patients with T2D

Janssen Pharmaceutical, a Johnson and Johnson company, announced the U.S. Food and Drug Administration (FDA) has granted priority review for the …

|